China's biomedical industry triumph hidden behind hidden - medicine - pharmaceutical industries
China's biomedical industry triumph hidden behind hidden - medicine - pharmaceutical industries
For the Yangtze River Delta, the country's innovative biological radiation Medicine Research Centre recently established in Suzhou, Beijing, development projects across the biomedical industry has officially launched during the same period. 2010 will be the biomedical industry in China breakthrough year. However, triumph over behind the biomedical industry, there are still a lot of worries, experts point out that radical biomedical industry "weak disorder" shall prescribe the right medicine.
Biomedical industry presents Negative effect and Precaution
Biomedical industry in recent years, the best growth, the development of one of the most active areas of the economy. To this end, all over the country are forging ahead with its development, bio-pharmaceutical industry "spark" the land of China is presented Negative effect and Precaution.
As a key development in Jiangsu Province in emerging industries, bio-pharmaceutical industry of Jiangsu nearly 200 billion yuan in output value, the total size of about 11.5% of the country, formed in Suzhou, Nanjing, Taizhou and Lianyungang and a number of pharmaceutical R & D an important base.
Jiangsu Science and Technology Department ZhuKejiang that create and promote independent intellectual property rights and the international competitiveness of the bio-pharmaceutical industry, is the industry to upgrade the natural choice for the current driving the new engine of economic growth.
According to "Shanghai Biological Medicine Industry Development Action Plan (2009-2012)" to the end of 2012, the city will initially be built innovative products of domestic manufacture of bio-medicine center, business center and R & D centers; bio-pharmaceutical industry total economic reached 200 billion yuan; In addition, Shanghai also support 100 more than 200000000 yuan in output value of innovative companies, creating 100 Sell Amount of more than 100 million yuan, high technology leading products.
Beijing next 3 years to achieve the overall size of bio-pharmaceutical industry hundreds of billions of goals, recently launched development projects across the biopharmaceutical industry, that G20 project. Size by 17 companies and six potential business support, energy savings industry, enhance industrial competitiveness.
Chongqing Municipality will invest 100 million yuan the next three years to build a strategic emerging biomedical industry. Efforts to break through the key 100 biomedical technology, led 10-15 in the drug research and industrialization, focusing on a large variety of 15-20 reform, and strive to add value over 30 billion yuan.
"Biomedical industry is not only about the health of the people, it is the embodiment of a comprehensive national strength, social development and economic growth will play an important role." Science and Technology of China Biotechnology Development Center, said deputy director of An Daochang.
Triumph and hidden behind the hidden
Biomedical industry for its high input, high risk, high-yield "three high" characteristics of a new round of global competition, the focus of high-tech industry, is the recent focus on the development of China's emerging strategic industries. After 10 years of efforts, China has basically built a business as the main incubator of innovative medicines to improve the level of drug development and industrialization; formed a specialization of a certain size new drug development teams, and strengthen the enterprise's technological innovation capability.
Although biomedical industry triumph, but there are some disadvantages to the constraints of its high precision and advanced the direction of advance, the most prominent independent innovation capability as the core advantage of the weak and small businesses both in the "weak disorder."
? Weak independent innovation ability Biomedical industry as capital, technology, knowledge-intensive industries, efficient R & D innovation is the lifeblood of their development, thus, in the drug development occupies a principal position in the company's high R & D investment are particularly important. Due to the lack of large core enterprise and related investment and financing channels, China's shortage of funding biomedical research and development, making it difficult to develop new products with independent intellectual property rights. At present, chemical drugs and biotech drugs to imitation, the surviving cell technology and a certain gap between the international comparison, Traditional Chinese medicine Preparation process level quality standards and research base is still weak.
Statistics show that China has approved the listing of the 13 categories of 25 kinds of 382 different specifications of the basic engineering medicine and genetic engineering vaccine, the only Category 6 9 21 products with different specifications are original, the others are imitation.
Talents in innovation, high-level R & D manpower shortage, especially the lack of progress and master the international forefront of key technologies, ability to open up a market leader in talent.
Ex-GlaxoSmithKline Executive, Lauren Stevens, alleged in drug fraud Staten Island Medical Billing And Coding – For Vast Career Opportunities Accurate and Timely Medical Billing Services The Right Medicine For Bipolar Outsourcing Medical Billing and Coding Services Second half of 2008 investment strategy report pharmaceutical industry - pharmaceutical industry, raw material medicine - pharmaceutical industry Denver Medical Malpractice Lawyer Your Permit Against Wrong Options Medicine Or Talk Therapy: Common Bipolar Disorder Treatment A DICOM Router And Viewer For Medical Office Productivity Latest Drug Recalls and Bad Press for Pharma Train Spotlight on Lean Manufacturing What are You Expecting at Drug Rehab The first national "zero difference" test report the hospital drug sales - zero difference - the pharmaceutical industries Drug And Alcohol Treatment Center Scholarships
China's biomedical industry triumph hidden behind hidden - medicine - pharmaceutical industries